Drchrono vs Phreesia: Which One in 2026?

Medical practices asked "Drchrono or Phreesia" are usually being asked the wrong question. One product is a cloud EHR and practice-management tenant. The other is a front-door intake, eligibility, and payment layer that writes into whatever chart you already have. Neither prints a list price.

TL;DR: Choose Drchrono when you need the legal medical record, e-prescribing, templates, and a claims path in one tenant. Choose Phreesia when the chart is staying and the failure is the clipboard: ID, consents, coverage, and copay before the nurse rooms the patient. They can sit together. They cannot replace each other. Both are quote only, so ask for seats, locations, visit-volume bands, write-back, extract format, and the dual-run month rather than scoring a demo on color.

How we evaluated

This page is a criteria pass. We scored Drchrono and Phreesia against six jobs: hold the chart, capture intake, verify coverage, collect at check-in, produce a claim, and hand the next outreach job to a person or an agent.

We did not add a third vendor. The title is a two-product question, and a shortlist would hide the category split that is the actual finding.

We printed no dollar figure next to either name. Both sit outside the store we can cite. A guessed per-provider or per-visit rate would be the number a partner repeats on a sales call.

The operating envelope is large enough that a wrong category pick is expensive in staff time, not just in license line items. National health spending hit $5.3 trillion in 2024. The spend sits on physician services as well as hospitals: according to CMS, national health spending grew 7.2% to $5.3 trillion in 2024, or $15,474 per person, with physician and clinical services at $1,109.7 billion.

Documentation load decides whether physicians will live in Drchrono: according to American Medical Association, 43.2% of physicians reported at least one burnout symptom in 2024, and more than one-third of respondents named ineffective EHR systems, in-basket work, and after-hours documentation as a stress source.

Charting software is already ubiquitous, which is why Phreesia can exist as a layer instead of as a record: according to CDC, the 2024 National Electronic Health Records Survey found that 95.0% of U.S. office-based physicians had adopted EHR systems, with 83.6% using a certified EHR.

Neither vendor publishes a list price. Commercial cells stay quote only.

Who Drchrono is for

Drchrono is for independent medical practices and specialty clinics that need a certified EHR, tablet charting, e-prescribing, and a practice-management layer in one cloud tenant.

The buyer is a group whose physicians will live in the note. The office manager still needs a scheduler and a claims path, but the product is chart-first. A clinic that already has a stable EHR and only wants a better waiting room is not this buyer.

Ask the quote for rendering providers, locations, in-house versus vendor billing, specialty templates, eRx, telehealth, and the CCD or FHIR extract when you leave. The answer is quote only.

Drchrono will store a finished intake packet. It will not replace a dedicated check-in rail. If your failure is the clipboard, keep reading.

Who Phreesia is for

Phreesia is for medical practices that already own a chart and need the front door: registration, insurance capture, consents, copay, and a packet that writes back before rooming.

The buyer is a multi-location or high-throughput clinic whose current EHR is staying put. A practice with no EHR looking for a system of record is not this buyer, even if the waiting-room demo is polished.

Ask the quote for locations, visit-volume bands, payment-facilitation terms, which EHR the intake writes to, and who owns patient-entered history after you leave. Public list price is not published.

Phreesia will not e-prescribe, will not hold the legal note, and will not be the claims workqueue. If those jobs are in scope, you are shopping Drchrono or you are shopping both.

EHR versus intake: the actual split

Price policy: no printed figure for Drchrono or Phreesia. Ask each vendor for seats, modules, volume bands, and migration.

They are not close. A scorecard that averages "ease of use" across these two rows is how a practice buys an intake layer and then discovers it has no chart, or buys an EHR and then discovers the clipboard is still on the counter.

Eligibility is the shared rail. the other product has to expose the remaining eligibility miss and the prior-auth miss inside the PM, and the other product has to capture coverage at the door and still hand the exception to a person: according to CAQH, medical plans reached 96% fully electronic eligibility verification in the 2024 Index while prior authorization sat at 35% electronic, with a $20 billion savings opportunity if remaining manual and portal work moved fully electronic.

Source: 2024 CAQH Index Report, medical plan adoption.

Hospital and physician spend is the other numeric frame, because intake failures and charting failures leak different slices of the same bill: according to KFF, hospital care accounted for 40% of national health spending growth between 2022 and 2024, while physician and clinical services accounted for 22% of that growth.

Sources: CMS NHE Fact Sheet; KFF hospital-spend note (Feb 2026); CDC NEHRS 2024 results.

95.0% of office physicians already use an EHR. That is why a Drchrono-versus-Phreesia demo that never asks "do we already have a chart" is a wasted hour.

Prior authorization and care-gap work sit after whichever product you pick. US Tech Automations can track a prescription PA through the CoverMyMeds-style loop so the nurse is not refreshing a portal, which is the job in the Rx prior-authorization tracking guide. Drchrono may store the order; Phreesia will not. Neither is the PA workqueue unless you build one.

Care-gap outreach is the same pattern. After the chart exists, US Tech Automations can run the outreach list for open gaps so the campaign is not trapped in an in-basket, which is the comparison in the care-gap closure guide. Phreesia might collect a screening form at check-in. Drchrono might hold the problem list. The chase is still a separate step.

Larger groups watching hospital EHR factories should not confuse that story with this page. The Epic agent-factory explainer is about a different scale of chart. Drchrono is an independent-practice EHR. Phreesia is an intake layer. Neither is a health-system core.

Pros and cons

Drchrono

Pros: holds the legal chart, tablet templates, eRx, and a path to claims in one tenant, which is the actual system-of-record buy.

Cons: intake is not the product, so the clipboard can survive the install, and every commercial term including the extract is quote only.

Phreesia

Pros: owns check-in, coverage capture, and copay before rooming, and is designed to write into an EHR you are not ripping out.

Cons: not the medical record, not eRx, not the claims workqueue, and the quote hinges on volume and payment terms you cannot read off a webpage.

Switching cost when you keep the chart and change the front door

The switching cost depends on which product is the destination, because the data you move is not the same.

If Drchrono is the new system of record, you are doing an EHR conversion: notes, problems, meds, allergies, documents, appointments, balances, eligibility logs, plus lab, eRx, and clearinghouse reconnects. Plan a 30-day dual-run of the appointment book, a claims shadow until the first ERA posts clean, and a training week when physicians chart slower. Demand a named extract format in the statement of work.

If Phreesia is the new front door, the EHR stays. You are converting form libraries, device/kiosk setup, copay posting rules, and the write-back map. Dual-run the clipboard and the new intake for a short window so a failed write-back does not empty the nurse's packet. Retraining is front desk and MA, not the full physician panel, unless you also change the chart.

If you install both, sequence Phreesia after Drchrono templates exist, or you will map intake fields twice. Do not cut over eligibility, PA tracking, and care-gap outreach in the same weekend as either go-live.

The month it takes is staff time. Incomplete packets, eligibility exceptions, and PA status will spike. Name an owner inside the practice for each. The vendor's implementation manager is not that owner after training.

There is no printed price to compare. Compare extracts versus write-back maps, then look at leftover chase work on the US Tech Automations homepage and how that work is sold on the pricing page.

Verdict: Drchrono or Phreesia

Pick Drchrono if you need the chart.

Pick Phreesia if you already have the chart and need the front door.

Pick both if the physicians need a new EHR and the waiting room is still a clipboard. That is a pair, not a tie.

Do not average the scores. An average score is how a practice buys the wrong category. Put the criteria table in the partner folder with the quote-only cells blank, fill them from signed quotes, and assign PA tracking and care-gap outreach as named jobs. US Tech Automations does that leftover layer; it does not replace the category vote.

See examples of those leftover steps before you treat either demo as complete.

Charting versus the front-door packet

Drchrono is an EHR-shaped product. Phreesia is an intake and access layer that sits in front of the visit. A practice that cannot finish a packet before the patient is roomed does not have an EHR problem first. A practice that cannot chart and charge does not have a kiosk problem first.

HIMSS: 78%+ already have an EHR. KFF: admin is ~25% of spend. Incomplete intake is how you donate that admin. Quotes only. EHR write, device/kiosk, and whether the packet lands without retype. Date the PDFs. Do not dual-run two intake paths in peak season.

Packet complete before "here"

Time the current intake. If it finishes after the patient is in the chair, Phreesia-shaped access is the first purchase even if the EHR demo was prettier. Drchrono-shaped EHR is first only if charges and notes are the empty object. HIMSS 78%+. Do not dual-run kiosks.

Time intake today. If it finishes after rooming, access layer first. If charges miss, EHR first. Phreesia-shaped vs Drchrono-shaped. HIMSS 78%+. No dual kiosks in peak season. Quotes dated, EHR write named.

FAQs

Are Drchrono and Phreesia substitutes for each other?

No. Drchrono is a medical EHR plus practice management; Phreesia is an intake, eligibility, and patient-pay layer that writes into a chart you still have to own.

Can we run Phreesia in front of Drchrono?

Yes. That is a coherent pair when you need a new chart and a dedicated front door, provided you map write-back after templates exist.

Does either vendor publish a price we can print?

No. Drchrono and Phreesia are both quote only on this page, so ask for seats, locations, volume bands, modules, and migration as line items.

Who should own eligibility if we only buy Phreesia?

Phreesia can capture coverage at the door, but portal exceptions and 270/271 failures still need a named owner in the PM or an agent layer.

How long is a Drchrono cutover versus a Phreesia cutover?

Plan 30 days of dual-running the book and a claims shadow for Drchrono; plan a shorter dual-run of clipboard versus kiosk for Phreesia, with write-back tested before you drop paper.

Will Phreesia close care gaps by itself?

No. It can collect a form at check-in. Outreach to patients who never booked is a separate campaign sitting on the chart's gap list.

Should prior authorization move in the same weekend as the EHR?

No. Keep the current PA loop through the first clean week, then attach tracking to the new order path once eRx and the workqueue are stable.

What if we already have an EHR and still need Phreesia?

That is common. HIMSS 78%+ already have an EHR. Intake can still fail. Access layer first if packets finish after rooming. EHR first if charges miss. Not both in peak season.

Key Takeaways

• Drchrono is the chart; Phreesia is the front door; they are not interchangeable.

• They can sit together; averaging their demo scores hides the category split.

• 43.2% of physicians reported burnout in 2024, so extra clicks in the note are a staffing issue.

• Neither vendor publishes a list price; every commercial cell is quote only.

• Dual-run the book for an EHR swap, and dual-run the clipboard for an intake swap.

• Assign PA tracking and care-gap outreach as named jobs on top of whichever product you pick.